Case Study – Tau Pathology

19th Apr 2022

Working in close collaboration with the manufacturer of a novel treatment for Progressive Supranuclear Palsy, MRN played a major role in delivering Home Trial Support (HTS) for 79 patients in several different countries.

Back to the resources